FilingReader Intelligence
Santen Pharmaceutical repurchases $47m shares in buyback program
August 1, 2025 at 12:09 PM UTC•By FilingReader AI
Santen Pharmaceutical repurchased 4.2 million shares for JPY 7.0 billion in July as part of its larger buyback program.
The company has now repurchased 8.6 million shares totaling JPY 14.1 billion under the program approved in May, which authorizes buying up to 19.8 million shares for a maximum JPY 35.0 billion through November.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
News Alerts
Get instant email alerts when Santen Pharmaceutical publishes news
Free email notifications • Unsubscribe anytime